2004•Journal watchRequires access

Long-Term Follow-Up of Monoclonal Gammopathy of Undetermined Significance

Allan S. Brett

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is characterized by serum monoclonal protein levels of 3 g/dL or lower and no clinical evidence of myeloma or related disorders. By some estimates, about 3% of people have MGUS by age 70. Researchers now provide complete follow-up of 241 patients with MGUS who were first seen …

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Monoclonal gammopathy of undetermined significance, Monoclonal gammopathy, Medicine, Multiple myeloma, Monoclonal, Clinical significance, Monoclonal antibody, Internal medicine